BPC-157 is studied to better understand tissue repair signaling, vascular pathway activation, and the mechanisms behind mucosal and connective tissue healing.

BPC-157 occupies a well-established position in preclinical repair signaling research, with a mechanistic profile that spans nitric oxide pathway modulation, VEGF and EGF growth factor upregulation, FAK-paxillin cell adhesion signaling, and VEGFR2-mediated angiogenesis — all characterized across distinct tissue and injury model preparations.

What distinguishes BPC-157 as a research tool compound is the breadth of its tissue applicability. The same core signaling mechanisms — nitric oxide system engagement, growth factor induction, and focal adhesion kinase pathway activation — have been studied in gastrointestinal mucosal, tendon, ligament, endothelial, and neural cell preparations, making it a versatile reference compound across multiple preclinical research disciplines.

• CAS Number: 137525-51-0
• Molecular Weight: 1419.53 Da
• Purity: ≥99%
• Also Known As: Body Protection Compound 157, PL-10, PL 14736, Bepecin, Gastric pentadecapeptide BPC-157
• Chemical Formula: C₆₂H₉₈N₁₆O₂₂

In cell-based and preclinical models, BPC-157 engages the nitric oxide (NO) signaling system as a primary mechanistic pathway — modulating eNOS activity and NO bioavailability in vascular and mucosal cell preparations. This NO-dependent activity has been associated with cytoprotective and vasodilatory signaling responses in gastrointestinal and endothelial tissue models, and is proposed as a central mechanism underlying its mucosal healing activity across multiple rodent injury preparations.

Growth factor upregulation represents a second well-characterized signaling arm. In wound site preparations, BPC-157 exposure is associated with concentration-dependent increases in VEGF and EGF expression — driving angiogenic and epithelial repair signaling through their respective receptor pathways. VEGFR2 phosphorylation and downstream FAK activation in endothelial cell preparations confirm the VEGF-dependent nature of BPC-157’s angiogenic activity, distinguishing it from VEGF-independent angiogenic tool compounds in mechanistic research designs.

In tendon and connective tissue preparations, FAK-paxillin signaling pathway modulation has been directly characterized. Western blot analysis in rat Achilles tendon models following BPC-157 exposure confirmed concentration-dependent upregulation of FAK and paxillin phosphorylation — signaling events governing cell adhesion, cytoskeletal organization, and directional migration at wound sites. Histological outcomes in these models showed improved collagen fiber organization and increased tendon cross-sectional area, consistent with FAK-paxillin-mediated cell adhesion and matrix remodeling activity.

• Nitric Oxide System Modulation and Cytoprotective Signaling Studies
• VEGFR2-Mediated Angiogenesis and Growth Factor Upregulation Research
• Gastrointestinal Mucosal Repair and Cytoprotection Models
• Tendon and Connective Tissue Repair Signaling Research
• Collagen Organization and ECM Remodeling Assays
• Multi-Peptide Combination and Complementary Angiogenic Pathway Studies